Zimmer announced plans earlier this year to quietly acquire Biomet for $10.35 billion in cash and $3 billion in common stock. However, previous issues could derail the transaction, at least for a time.
↧
Zimmer announced plans earlier this year to quietly acquire Biomet for $10.35 billion in cash and $3 billion in common stock. However, previous issues could derail the transaction, at least for a time.